UCSF

Topics and Expertise: pharmacogenomics

Study discovers why leading gout medication is ineffective for many

Allopurinol, the first-choice medication for treating gout—an excruciatingly painful condition that is the most common form of inflammatory arthritis, afflicts more than eight million Americans, and is on the rise worldwide—is not fully effective in more than half of patients.

Major Mexican genetic study uncovers basis for health differences among Latinos

The most comprehensive genetic study of the Mexican population to date has revealed as much genetic differentiation as the variation between some Europeans and Asians.

Xin Chen, PhD

Professor

I study molecular genetics and signaling pathways in liver cancer development with the goal to develop better targeted therapy for this deadly malignancy.

Brian Alldredge, PharmD

Vice Provost-Academic Affairs

My clinical practice and research focus on the drug treatment of epilepsy and the genetic, behavioral, and environmental factors that influence drug response.

Deanna Kroetz, PhD

Department Chair & Professor

Our lab seeks to understand the molecular basis of interindividual variation in drug response and toxicity. We investigate genetic differences in chemotherapy-induced peripheral neuropathy and other cancer drug phenotypes and search for new therapeutic approaches targeting ABC transporters.

Kathy Giacomini, PhD, BSPharm

Dean-School of Phrmcy/AssocVC

As dean of the UCSF School of Pharmacy, I set the School’s strategic agenda and ensure it has the resources and organizational structure required to succeed in its mission. I bring my scientific expertise and background in pharmacy in support of our groundbreaking research, individualized patient...

Leslie Benet, PhD

Professor

Child’s illness fuels lab team’s search for early-life epilepsy diagnostics

The lab of UCSF School of Pharmacy faculty member Nadav Ahituv, PhD, studies how abnormalities in DNA segments that control the activity of genes could lead to diseases.

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support

Giacomini to receive Therapeutic Frontiers Lecture Award

Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, will receive the 2010 Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy on October 17, 2010, in Austin, Texas at

Pages